GBP2 and breast cancer: We next tested increased GBP2 levels to determine the function in breast cancer cells with low GBP2 expression and found that exogenous GBP2 transfection led to a greater inhibition of metastasis in cells than did IFN-γ treatment (Figure 1a,Figure 2a).